Onycho Pharma has acquired rights for Amycot® in the USA and will conduct a clinical trial program to permit out-license of product for commercialisation as a prescription medicine. Amycot® is a highly efficacious natural treatment to manage onychomycosis using a patented bioactive extract from the...See more
Headquarter Singapore |
Countries of operation Singapore |
Year founded 2019 (5 years) |
Funding status Private |
Company type SME |
The company has a sophisticated ownership structure and may be part of a large corporate group
Auditor: | SINGAPORE ASSURANCE PAC |
Share Capital - Ordinary shares: | hidden.item |
Sign up to view for free | |
Company | Incorporation date | Country of Registration | Share capital | Local SIC |
---|---|---|---|---|
| 25 Nov 2019 | Singapore | USD 958,659 | 47729: RETAIL SALE OF PHARMACEUTICAL AND MEDICAL GOODS N.E.C. |